July 3 (Reuters) - U.S. private equity firm Carlyle Group CG.O is preparing to offload up to a 10% stake in India's Piramal Pharma PIRM.NS through block trades, online news portal Moneycontrol reported on Thursday, citing sources.
The U.S.-based private equity firm could earn in the range of 26 billion rupees ($304.8 million) to 27 billion rupees from the sale, the report added.
($1 = 85.3090 Indian rupees)
(Reporting by Hritam Mukherjee in Bengaluru; Editing by Nivedita Bhattacharjee)
((Hritam.Mukherjee@thomsonreuters.com; X: @MukherjeeHritam;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。